Showing results (91-100 of 537) with videos related to

Sort By:
Pageof 54
Expert Opinion on Emerging Drugs|May 26, 2020
Emerging 5-HT receptor antagonists for the treatment of SchizophreniaMackenzie T Jones, Martin T Strassnig, Philip D Harvey
The American Journal of Psychiatry|October 4, 2005
Treatment of cognitive impairment in early psychosis: a comparison of risperidone and haloperidol in a large long-term trialPhilip D Harvey, Jonathan Rabinowitz, Marielle Eerdekens, et al.
Bipolar Disorders|July 15, 2009
The factor structure of clinical symptoms in mixed and manic episodes prior to and after antipsychotic treatmentPhilip D Harvey, Jean M Endicott, Antony D Loebel
The Journal of Neuropsychiatry and Clinical Neurosciences|February 7, 2009
Depression in schizophrenia: methodological artifact or distinct feature of the illness?Eran Chemerinski, Christopher Bowie, Hannah Anderson, et al.
Journal of the International Neuropsychological Society : JINS|April 19, 2008
Functional implications of neuropsychological normality and symptom remission in older outpatients diagnosed with schizophrenia: A cross-sectional studyWinnie W Leung, Christopher R Bowie, Philip D Harvey
American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics|March 10, 2007
Dysregulation of X-linked gene expression in Klinefelter's syndrome and association with verbal cognitionMarquis P Vawter, Philip D Harvey, Lynn E DeLisi
Schizophrenia Bulletin|May 12, 2007
Performance-based measures of functional skills: usefulness in clinical treatment studiesPhilip D Harvey, Dawn I Velligan, Alan S Bellack
Innovations in Clinical Neuroscience|February 8, 2018
Insight and Treatment Outcomes in Schizophrenia: Post-hoc Analysis of a Long-term, Double-blind Study Comparing Lurasidone and Quetiapine XRPhilip D Harvey, Cynthia O Siu, Antony D Loebel
Neuropsychiatric Disease and Treatment|June 9, 2023
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia [Podcast]Carlos A Larrauri, Philip D Harvey, John M Kane
Schizophrenia Research|June 29, 2015
Effect of lurasidone dose on cognition in patients with schizophrenia: post-hoc analysis of a long-term, double-blind continuation studyPhilip D Harvey, Cynthia O Siu, Masaaki Ogasa, et al.
Pageof 54